Guardant Health
GH
#1704
Rank
โ‚น1.207 T
Marketcap
โ‚น9,108
Share price
-3.79%
Change (1 day)
163.29%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -โ‚น303.54

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น325.29. In 2025 the company made an earnings per share (EPS) of -โ‚น317.61 an increase over its 2024 EPS that were of -โ‚น341.60.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น303.54-4.43%
2025-โ‚น317.61-7.02%
2024-โ‚น341.60-16.82%
2023-โ‚น410.69-33.13%
2022-โ‚น614.1160%
2021-โ‚น383.8255.04%
2020-โ‚น247.56207.14%
2019-โ‚น80.60-19.81%
2018-โ‚น100.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น269.31-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น237.97-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA